Todays RegSHO short sale metrics are quite a laugh, did

New Post Public Reply Private Reply Replies (1) Message Board
EliteYoda

Todays RegSHO short sale metrics are quite a laugh, did anyone notice?

20120723|RFMK|1550000|0|2041100|O

Less than a half million shares were actually traded today if you net-out the short sales with the rest of the volume. Remember, the market participants and MMs can find shares to borrow and short them and then dump them on the bids of colluding MMs to manipulate the price down then wait for any RFMK longs to capitulate from the pain and snap up their shares to cover, at the lower price, thereby making their lunch money for the day. Rinse/repeat. Often the MMs work together in just shuffling shares around intraday to paint whatever volume and price points they want, effectively drawing whatever chart they wish so the trading tape is suspect. Less than 25% of the trading volume today was just simply shares getting bought and sold normally, all the rest were short sales and then covered later intraday. Many on "other" boards will tell you that these numbers mean nothing and show nothing other than the MM activity, as in legged-trades, however this is false. These are netted daily aggregate figures of short sales versus total volume. The affect in the numbers of the legged trades by MMs are already netted out and dealt with by the time these figures are reported daily by FINRA. They will further lead others astray by claiming that the T+3 settlement window is what distorts these numbers, but again, that is false. The T+3 settlement window has nothing to do with the ratio of the total short sale transactions versus the total volume, especially when dealing with so few shares traded intraday. We all know already that the bi-weekly short interest numbers show that there are no large short positions in the stock, therefore the only way to interpret the daily numbers from FINRA is to assume that the MMs are shorting and then covering intraday in order to game others (retail) trading in and out or accumulating or selling so they can make their daily lunch money. It is that simple. They often claim that the only way to interpret the action is to assume that there is more dilution going on and the MMs are shorting into the dumpage but this false claim like most does not make any sense, because MMs typically short bids that come in to buy the stock when the MM does not necessarily yet have any shares on hand. With dilution, one of the MMs already has a bunch of the clients shares (many times from the companys account) and wishes to dump them on buyers in the market so they would not go short until bids come in to purchase these shares. It does not mean they would not try to game this situation so that they are shorting every bid that comes in all the while knowing they have tons of shares they can set low on the ASK immediately after they rip through all the existing bids in order to push the pps as low as possible. In either case, there is no one to one correlation to dilution and how much shorting the MMs are doing based on the bid volume. There always has to be a buyer for unique shares to sell and if they short borrowed shares they then need to turn around and buy to cover real unique shares, very simple. The factor that is limitless is their ability to borrow and short X number of shares all the while knowing that there is a seller of X number of shares (or thereabouts) that could allow them to cover. Basically they have a free hand to short as much as they want at anytime as long as they can properly locate those borrowed shares to short. Even if there are no sellers to allow them to cover afterwards, the only limit for them is the number of properly borrowed shares their own risk assessment will grant them to short.

Based on my experience, once the short sale volume to total volume (intraday) moves higher than 75%, it is rather obvious and clear to anyone that the MMs are simply throwing the stock around like a rag doll and the price and volume movements mean absolutely nothing on a longer term scale because no one knows what is the future number of buyers and how many shares they could want. At anytime on big news, RFMK could become a household name because of all the amazing work Cheryl Shuman has done and very quickly there could be 10 large firms who wish to each own 10% of the O/S, that is only 100M shares each (large firms could easily wish to own $100k worth of stock) and there you go, just in that scenario is 100% demand for all the shares that exist which would sky rocket the price rather quickly and sharply. Obviously this is an extreme example, but many use a day to day perspective of sentiment and the daily price and puny volume movements as factors to guage the status of the company, which once one understands the MMs are playing with the stock like its a rag doll toy understand that such assumptions based on the meaningless daily action are completely and entirely faulty.

GLTA!

$RFMK!

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading